
    
      The goal of this application study was to answer the question as to whether the application
      of WO2085 Moisturising Cream for breast cancer patients undergoing chemotherapy or treatment
      with anti-oestrogens / aromatase inhibitors can result in an improvement in the subjective
      symptoms and objective diagnoses of vulvovaginal dryness while also ensuring good
      tolerability.
    
  